VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DOXAmdocs Limited
$58.36$6.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDOXFinancials

Amdocs Limited (DOX) Income Statement

29Y historyFree accessUpdated daily

Revenue growth has turned positive at 2.7% YoY in the latest quarter after six consecutive declines, while gross margin expanded to 39.8% from a low of 34.7% in 2024Q4, indicating a potential inflection point in profitability.

Income StatementBalance SheetCash FlowRatios

DOX Income Statement

Annual statement

DOX Income Statement

Amdocs Limited (DOX) annual income statement — 29-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Sales/Revenue4.65B4.53B5B4.89B4.58B4.29B4.17B4.09B3.97B3.87B3.72B3.64B3.56B3.35B3.25B3.18B2.98B2.86B3.16B2.84B2.48B2.04B1.77B1.48B1.61B1.53B1.12B626.9M403.8M290.1M
Revenue Growth %0.14%-9.43%2.4%6.79%6.72%2.87%2.02%2.81%2.78%4.01%2.05%2.24%6.51%3.05%2.18%6.48%4.25%-9.47%11.49%14.36%21.65%14.93%19.58%-8.07%5.19%37.16%78.39%55.25%39.19%-
Cost of Goods Sold2.89B2.87B3.25B3.16B2.96B2.81B2.76B2.65B2.6B2.51B2.41B2.35B2.31B2.17B2.09B2.07B1.91B1.83B2.03B1.8B1.58B1.3B1.12B913.36M933.34M853.24M645.52M332.7M213M169M
COGS % of Revenue-63.42%64.93%64.65%64.62%65.54%66.1%64.92%65.29%64.84%64.76%64.48%64.73%64.77%64.23%65.12%63.86%64.09%64.08%63.34%63.86%63.56%63.3%61.58%57.84%55.63%57.72%53.07%52.75%58.26%
Gross Profit1.76B1.66B1.76B1.73B1.62B1.48B1.41B1.43B1.38B1.36B1.31B1.29B1.26B1.18B1.16B1.11B1.08B1.03B1.14B1.04B896.22M742.97M650.9M569.97M680.23M680.67M472.8M294.2M190.8M121.1M
Gross Margin %37.81%36.58%35.07%35.35%35.38%34.46%33.9%35.08%34.71%35.15%35.24%35.52%35.27%35.23%35.77%34.88%36.14%35.91%35.92%36.66%36.14%36.44%36.7%38.42%42.16%44.37%42.28%46.93%47.25%41.74%
Gross Profit Growth %--5.54%1.61%6.7%9.57%4.54%-1.4%3.91%1.48%3.76%1.25%2.97%6.61%1.5%4.79%2.76%4.92%-9.49%9.23%16.02%20.63%14.14%14.2%-16.21%-0.06%43.97%60.71%54.19%57.56%-
Operating Expenses943.59M834.71M1.13B1.07B954.35M878.98M818.72M863.75M866.2M842.17M827.05M765.1M761.1M697.25M718.96M704M668.12M639.88M716.31M675.6M538.37M391.88M354.7M345.46M579.44M521.39M398.67M147.2M105.9M66.6M
OpEx % of Revenue-18.41%22.51%21.97%20.85%20.5%19.64%21.14%21.79%21.78%22.24%21%21.36%20.84%22.14%22.15%22.39%22.35%22.65%23.82%21.71%19.22%20%23.29%35.91%33.99%35.65%23.48%26.23%22.96%
Selling, General & Admin539.68M493.87M572.85M570.71M528.57M487.25M458.54M492.46M481.09M472.78M464.88M440.08M445.13M418.57M424.67M409.46M373.58M344.33M404.13M370.19M314M232.07M210.38M206.26M223.55M195.59M137M75.7M51.2M40.8M
SG&A % of Revenue-10.9%11.45%11.68%11.55%11.36%11%12.05%12.1%12.23%12.5%12.08%12.49%12.51%13.08%12.89%12.52%12.03%12.78%13.05%12.66%11.38%11.86%13.91%13.85%12.75%12.25%12.08%12.68%14.06%
Research & Development343.21M340.85M360.8M374.86M354.71M312.94M282.04M273.94M276.62M259.1M252.29M254.94M257.9M240.27M242.06M221.89M207.84M210.39M225.49M230.44M186.76M144.46M126.41M119.26M124.08M105.81M74.85M40.9M25.6M17.4M
R&D % of Revenue-7.52%7.21%7.67%7.75%7.3%6.77%6.7%6.96%6.7%6.79%7%7.24%7.18%7.46%6.98%6.96%7.35%7.13%8.13%7.53%7.09%7.13%8.04%7.69%6.9%6.69%6.52%6.34%6%
Other Operating Expenses3M0193.14M128.06M71.08M78.78M78.14M97.36M108.49M110.29M109.87M70.07M58.07M38.41M52.23M72.65M86.7M85.15M86.69M74.96M37.61M15.36M17.91M19.94M231.8M219.99M186.82M30.6M29.1M8.4M
Operating Income815.83M823.36M628.61M653.99M664.8M598.69M594.76M569.75M428.31M517.33M483.14M515.95M495.65M481.55M442.47M404.36M410.43M367.32M405.6M357.43M332.13M338.49M296.2M210.42M49.16M159.28M74.12M147M84.9M54.5M
Operating Margin %17.53%18.16%12.56%13.38%14.53%13.96%14.27%13.94%10.78%13.38%12.99%14.16%13.91%14.39%13.63%12.72%13.75%12.83%12.83%12.6%13.39%16.6%16.7%14.19%3.05%10.38%6.63%23.45%21.03%18.79%
Operating Income Growth %-30.98%-3.88%-1.63%11.04%0.66%4.39%33.02%-17.21%7.08%-6.36%4.1%2.93%8.83%9.42%-1.48%11.74%-9.44%13.47%7.62%-1.88%14.28%40.77%328.02%-69.14%114.88%-49.58%73.14%55.78%-
EBITDA1.02B1.02B821.67M849.69M889.33M807.52M793.17M775.52M639.53M732.22M694.93M690.74M658.42M622.33M602.09M585.84M606.37M565.44M598.53M522.43M450.03M432.32M397.08M307.87M358.98M441.91M229.48M177.6M114M62.9M
EBITDA Margin %22.03%22.48%16.42%17.38%19.43%18.83%19.03%18.98%16.09%18.93%18.69%18.96%18.48%18.6%18.54%18.44%20.32%19.75%18.93%18.42%18.15%21.21%22.39%20.76%22.25%28.81%20.52%28.33%28.23%21.68%
EBITDA Growth %13.45%23.99%-3.3%-4.46%10.13%1.81%2.28%21.26%-12.66%5.37%0.61%4.91%5.8%3.36%2.77%-3.39%7.24%-5.53%14.57%16.09%4.1%8.88%28.98%-14.24%-18.77%92.57%29.21%55.79%81.24%-
D&A (Non-Cash Add-back)209.16M195.44M193.07M195.7M224.53M208.83M198.41M205.77M211.22M214.88M211.79M174.79M162.77M140.78M159.61M181.48M195.94M198.12M192.94M164.99M117.9M93.83M100.88M97.45M309.82M282.63M155.36M30.6M29.1M8.4M
EBIT638M731.66M625.96M659.45M665.32M835.58M593.75M571.8M424.31M514.51M486.37M516.55M493.03M479.03M444.7M398.59M388.43M374.02M448.44M364.19M357.86M351.09M296.2M224.51M100.79M159.28M74.12M147M84.9M54.5M
Net Interest Income-43.15M-33.28M-17.44M-1.84M-9.09M-16.45M-6.19M2.31M3.84M6.37M5.15M1.47M-8.49M-2.79M2.3M1.08M3.81M8.51M11.96M00000000000
Interest Income-11.27M9.15M17.45M21.25M7.82M4.82M4.23M6.22M6.6M7.97M6.82M4.62M4.08M4.92M5.48M6.18M7.67M16.37M42.84M00000000000
Interest Expense31.89M42.44M34.89M23.09M16.91M21.27M10.43M3.91M2.76M1.6M1.67M3.14M3.48M3.56M3.17M2.88M3.13M7.87M30.88M00000000000
Other Income/Expense-232.29M-130.12M-37.54M-17.63M-16.39M215.61M-11.44M-1.86M-6.77M-4.42M1.56M-2.54M-6.1M-6.08M-948K-8.66M-25.14M-1.17M11.96M50.57M41.74M22.3M4.9M14.76M19.3M22.29M10.73M-6.3M-24.1M-30.8M
Pretax Income583.55M693.24M591.07M636.36M648.41M814.31M583.32M567.89M421.54M512.91M484.7M513.4M489.55M475.48M441.52M395.71M385.3M366.15M417.55M408M373.87M360.8M301.1M225.18M68.46M181.57M84.86M140.8M60.8M23.7M
Pretax Margin %12.54%15.29%11.81%13.02%14.17%18.99%13.99%13.9%10.61%13.26%13.04%14.09%13.74%14.21%13.6%12.45%12.91%12.79%13.2%14.39%15.08%17.7%16.98%15.18%4.24%11.84%7.59%22.46%15.06%8.17%
Income Tax126.01M125.47M94.75M93.4M98.91M125.93M85.48M88.44M67.14M76.09M75.37M67.24M67.43M63.04M50.15M49.04M41.39M39.98M38.65M43.06M55.24M72.16M66.24M56.29M73.52M115.18M78.88M42.2M30.4M17.8M
Effective Tax Rate %21.59%18.1%16.03%14.68%15.25%15.46%14.65%15.57%15.93%14.83%15.55%13.1%13.77%13.26%11.36%12.39%10.74%10.92%9.26%10.55%14.77%20%22%25%107.39%63.44%92.96%29.97%50%75.11%
Net Income454.66M564.7M493.2M540.71M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.1M5.9M
Net Margin %9.77%12.46%9.85%11.06%12.01%16.05%11.94%11.73%8.92%11.3%11.01%12.25%11.85%12.33%12.05%10.91%11.52%11.39%11.98%12.87%12.85%14.16%13.24%11.39%-0.31%4.33%0.53%15.71%7.45%2.03%
Net Income Growth %-18.05%14.5%-8.79%-1.6%-20.17%38.27%3.84%35.29%-18.87%6.72%-8.26%5.7%2.35%5.38%12.9%0.8%5.44%-13.92%3.83%14.53%10.39%22.9%39.07%3436.95%-107.62%1010.51%-93.93%227.24%410.17%-
Net Income (Continuing)457.53M567.77M496.32M542.96M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.4M5.9M
Discontinued Operations000000000000000000000000000000
Minority Interest40.98M41.23M42.2M43.17M42.51M42.51M42.51M42.51M43.16M000000000000000000000
EPS (Diluted)4.305.054.254.494.445.323.713.472.472.962.712.852.622.532.311.861.691.581.741.651.481.351.080.77-0.020.290.030.490.190.05
EPS Growth %-14.29%18.82%-5.35%1.13%-16.54%43.4%6.92%40.49%-16.55%9.23%-4.91%8.78%3.56%9.52%24.19%10.06%6.96%-9.2%5.45%11.49%9.63%25%40.26%3447.83%-107.93%866.67%-93.88%157.89%280%-
EPS (Basic)-5.084.274.524.475.363.733.492.492.992.742.892.652.562.331.871.701.611.831.761.571.441.130.78-0.020.300.030.500.190.05
Diluted Shares Outstanding105.69M111.75M113.96M118.49M121.89M127.97M133.25M137.16M143.7M147.43M151.18M156.81M161.34M163.12M169.44M186.56M204.08M207.61M219.61M223.26M218.53M217.16M220.28M219.88M220.36M226.83M216.94M200.26M159.44M196.8M
Basic Shares Outstanding105.45M111.15M113.3M117.66M121.05M127.18M132.61M136.47M142.42M146.02M149.17M154.42M159.01M161.33M168.28M185.21M202.58M202.87M206.59M207.85M203.19M201.02M208.73M215.85M220.36M222M212M197.44M158.53M196.8M
Dividend Payout Ratio-39.74%42.98%36.89%33.86%25.78%32.95%30.79%37.89%27.82%26.7%22.59%21.54%20.37%--------------1590.37%305.08%

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Sustained revenue contraction in core vertical

Revenue Contraction Persists Despite Recent Uptick

Amdocs' revenue growth has been negative for six consecutive quarters, with the TTM decline at -9.4%, though the most recent quarter showed a modest 2.7% YoY increase, suggesting a potential stabilization from a deep trough.

The sustained period of negative growth, as reported in the financial statements, indicates a significant slowdown in carrier digital transformation spending or project timing delays. The recent positive quarter may represent a cyclical bottoming, but the durability of this recovery is uncertain given the company's historical reliance on lumpy, large-scale project wins. Investors should monitor whether this uptick is a one-time milestone recognition or the beginning of a genuine demand recovery.

Gross Margin Recovery Amidst Revenue Pressure

Gross margin expanded to 39.8% in the latest quarter, a significant improvement from the 34.7% low in 2024Q4, suggesting improved project mix or cost discipline despite the challenging revenue environment.

The margin expansion, based on reported figures, appears to be driven by a more favorable mix of higher-margin software and managed services versus lower-margin implementation work. However, this improvement has not fully translated to the bottom line, as net margin remains compressed at 5.3% in the latest quarter. This divergence suggests that non-operating items or tax effects are currently masking the underlying operational improvement.

Operating Leverage Demonstrated in Recent Quarter

Operating income grew 4.3% YoY in the latest quarter on just 2.7% revenue growth, indicating effective cost control and the inherent operating leverage in the business model when revenue stabilizes.

The ability to grow operating income faster than revenue, as seen in the latest period, suggests management has successfully aligned its cost structure with the lower revenue base. This is a positive signal for margin resilience. However, the leverage is currently being driven by cost containment rather than revenue growth, which is a less sustainable path to long-term profitability expansion.

SG&A Discipline Offsets R&D Investment

SG&A expenses as a percentage of revenue have been reduced from 11.6% in 2024Q2 to 12.4% in the latest quarter, while R&D spending has remained relatively stable, indicating a focus on overhead efficiency.

The reduction in SG&A intensity, as reported in the financial statements, appears to be a key driver of the improved operating margin profile. This suggests management is actively managing discretionary spending to protect profitability during the revenue downturn. The stability in R&D spending is noteworthy, as it implies the company is maintaining investment in its cloud-native platform despite near-term headwinds.

Net Margin Fragility and Earnings Quality Concerns

The persistent gap between operating margin (18.0%) and net margin (5.3%) in the latest quarter, coupled with a -57.6% YoY decline in EPS, raises questions about the quality and sustainability of reported earnings.

The significant divergence between operating and net profitability, based on the provided data, suggests that non-operating costs, tax provisions, or other below-the-line items are heavily impacting the bottom line. The sharp EPS decline despite stable operating income warrants further investigation into the specific drivers. This pattern could indicate that the company's core operational performance is stronger than the headline earnings suggest, but it also introduces volatility and uncertainty for investors.

DOX — Frequently Asked Questions

Quick answers to the most common questions about buying DOX stock.

What was Amdocs Limited's (DOX) revenue in 2025?

For fiscal year 2025, Amdocs Limited (DOX) reported total revenue of $4.53B. This represents a 1462.5% increase compared to $290.1M in 1997.

Is Amdocs Limited (DOX) profitable?

Amdocs Limited (DOX) is profitable, generating $564.7M in net income for the fiscal year ending 2025 with a net profit margin of 12.5%.

What is Amdocs Limited's operating profit margin?

Amdocs Limited (DOX) reported an operating income of $823.4M, resulting in an operating profit margin of 18.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Amdocs Limited's gross profit and gross margin?

Amdocs Limited (DOX) generated $1.66B in gross profit for the year, representing a gross profit margin of 36.6%. This demonstrates the company's core pricing power and production efficiency.